The Need for Development of Parkinson's Disease Therapeutics
-
Disease-modifying therapeutics
Current therapeutics are limited to symptom management, so the development of fundamental therapeutics capable of controlling disease progression is required.
-
Companion Diagnostics
Therapeutic strategies linked to companion diagnostics are required for precise patient selection and evaluation of therapeutic response.
-
Quality of Life Improvement
The therapeutic goal is to maintain and improve the patient's activities of daily living functions and quality of life in the long term.
